Business
Column: Is UCLA 'a failed medical school'? Debunking a dumb right-wing meme
The right-wing and Republican project to eradicate diversity and inclusiveness from American society has become more absurd with every passing day, but it will be hard for anyone to produce a more vapid and fatuous effort than a recent article labeling UCLA’s David Geffen School of Medicine as a “failed medical school.”
The reason for that label, according to the right-wing Washington Free Beacon, which published the article, is that UCLA has “prioritized diversity over merit, resulting in progressively less qualified classes that are now struggling to succeed.”
To its perverse credit, the Beacon doesn’t conceal the racist import of its claims; on the contrary, it announces it outright, citing the school’s “race-based admissions” and quoting one of its anonymous sources (there is no other category) as saying, “We want diversity so badly, we’re willing to cut corners to get it.”
We’re not backing off from diversity, equity and inclusion in our medical school curricula. It’s really intended to train the next generation of physicians to respond appropriately to a rapid growth in diversity.
—
Steven Dubinett, dean, UCLA School of Medicine
An admissions officer is quoted anonymously as grousing, “All the normal criteria for getting into medical school only apply to people of certain races. For other people, those criteria are completely disregarded.”
The article purports to rely on complaints from eight of the school’s faculty members. The medical school’s full-time faculty numbers more than 2,000, with an additional 2,000 to 2,500 part-timers or adjuncts. That should give you a clue to how deeply the Beacon delved into the facts before issuing its eye-catching conclusion.
But that’s only one aspect of a piece that trips over its supposed “facts” at almost every turn, openly cherry-picks data to confirm its biases, and treats every factoid as an artifact of the quest for diversity. Its author doesn’t even appear to understand the difference between the student admissions process and the process of accepting residents, who are medical school graduates, many if not most of whom received their medical education elsewhere.
“I consider it to be fact-free,” Steven M. Dubinett, the school’s dean, told me about the Beacon article. He’s being kind.
Before delving into the article itself, a few words abut the Washington Free Beacon. The Beacon was founded in 2012 with funding from, among other conservatives, hedge fund billionaire Paul Singer. Its first editor was co-founder Matthew Continetti, who is a son-in-law of conservative pundit Bill Kristol.
The Beacon’s driving impulse appears to be “owning the libs,” as shown by its preening over its role in advancing the criticism of former Harvard President Claudine Gay for what many in the academic community regard as trivial cases of plagiarism.
That scandal-mongering was basically the handiwork of right-wing attack dog Christopher Rufo, who carried the theme further by accusing other Harvard figures of plagiarism; curiously, as the Harvard Crimson notes, they were all Black women, like Gay.
The Beacon’s tone was described as “puckish” by a Washington Post writer who apparently doesn’t know what “puckish” means; he praised it in the same article as standing a hair above other right-wing websites, which strikes me as a bit like trying to identify the best “Sharknado” movie. The basis of his praise was that the Beacon “does significant reporting of its own.” But if “significant” means “cogent,” that quality isn’t much in evidence in the article about UCLA.
So let’s pick up our endoscopes and take a look inside.
The main target of the article is Jennifer Lucero, who became associate dean for admissions in June 2020. The article posits that her arrival in that post, and her focus on diversity, led to a precipitous drop in the quality of incoming students. More on that in a moment.
The article’s empirical assertions, such as they are, start with the annual medical school rankings of U.S. News and World Report. These have been controversial for years, in part because their methodology is suspect. As a result, many of the top-ranked schools have stopped cooperating with them, though the University of California still participates.
The article’s author, Aaron Sibarium, wrings his hands over the fact that UCLA’s ranking in “research” has fallen to 18th from sixth place in just the first three years after Lucero’s arrival.
Couple of problems there. One is that research ranking tracks the activities of faculty members, not students. It has nothing to do with the record of the incoming class. Dubinett says that one reason UCLA may have fallen in the rankings is that it has assigned more faculty to clinical education rather than research, so the grant level per faculty has naturally declined.
But that’s not the only measure of research quality. Consider the grant approvals by the National Institutes of Health, the nation’s leading source of public grants in medicine. UC as a whole has consistently been a top recipient of NIH grants — ranking first in the nation since at least 2000 and probably for much longer than that. For most of that period, UCLA has been the second-largest recipient among UC campuses behind the research powerhouse of UC San Francisco.
From 2010 through 2019 and again in 2022 UCLA fell to third behind UCSF and narrowly behind UC San Diego, but for three of the four years of Lucero’s tenure it’s been second. There’s no sign there of a decline in research stature.
Sibarium, who did not respond to a request for comment, deserves an F in that category but an A for cherry-picking. On the other metric that U.S. News uses consistently, primary care, UCLA has risen in rank since 2020, to 10th in the nation from 11th. And in other categories, the school’s ranking has risen since 2020 — for example to seventh from 10th in internal medicine and sixth from 12th in pediatrics.
Sibarium’s other “gotcha” concerns the UCLA students’ records on shelf exams, which are given after each clinical rotation. He asserts that their failure rates have risen precipitously during the Lucero era: “As the demographics of UCLA have changed,” he writes, “the number of students failing their shelf exams has soared.” He quotes a professor, anonymously, saying, “Faculty are seeing a shocking decline in knowledge of medical students.”
But as he acknowledges, UCLA dramatically changed its academic schedule in 2020. Along with many other top schools, it moved students out of the classroom in the second of their four years of education, instead of waiting for the third. That deprived students of a full year of clinical training before they took the shelf, so of course they did worse. But the official chart illustrating Sibarium’s article shows that the failure rate on most clinical specialties has fallen as the students progressed from Year 2 to Year 3.
“The challenge of moving the exams earlier has been written about,” Dubinett says. But the trend lines show that by the end of their third year, well more than 90% of UCLA’s students are passing the shelf exams in almost every clinical discipline.
The Beacon’s brief against Lucero is tied to its evident resentment of diversity programs. Sibarium points to a required first-year course titled “Structural Racism and Health Equity,” which comprises “three to four hours every other week,” as though a twice-monthly course is supposed to be an unsupportable burden to medical students.
Is there a point to that sort of training? Of course there is: “We’re cognizant that more than 80% of health is based on social determinants,” Dubinett says, pointing out that the phenomenon was very much on display in racial and ethnic disparities in treatment and outcomes during the pandemic.
“These inequities result, in large part, from racial and ethnic minority populations’ inequitable access to health care, which persists because of structural racism in health care policy,” according to a 2022 paper in Health Affairs.
“We’re not backing off from diversity, equity and inclusion in our medical school curricula,” Dubinett says. “It’s really intended to train the next generation of physicians to respond appropriately to a rapid growth in diversity.” In few other places are the impacts of inattention to social conditions more evident than in Los Angeles, he says. “We can look no further than what’s outside our front door — if I drive 15 minutes to the south from my office, life expectancy falls by 15 years.”
The Beacon even states that diversity efforts at UCLA may be illegal or unconstitutional, since the state’s voters outlawed racial preferences at public institutions in 1996 and the U.S. Supreme Court overturned them nationwide last year.
To support this absurd claim, Sibarium turns to Adam Mortara, the lawyer who represented the plaintiffs in the Supreme Court case. Asking for information about an applicant’s race when “no lawful use can be made of it” is “presumptively illegal,” Mortara said. He added, “You can’t have evidence of overt discrimination like this and not have someone come forward” as a plaintiff.
The problem here is that there’s no evidence that the medical school has applied racial or ethnic standards to its applicants. Sibarium admits as much: The application committee “for students does not see the race or ethnicity of applicants,” he writes. So where’s the beef?
Sibarium insinuates that Lucero has exercised undue influence over residency acceptances. But he finds that she’s a member of the hiring committee only for anesthesia residents (anesthesia is Lucero’s medical specialty). Couple of issues here. One is that almost no one gets hired for a medical residency anywhere without an interview, either in person or by zoom, which is designed to give the committee a holistic sense of the applicants’ character and personality, not just their test scores.
Another is that by the author’s own admission, Lucero hasn’t been especially effective in instituting diversity tests for anesthesia residents. He cites one case in which she advocated that a white candidate be ranked downward and another in which she “insisted that a Hispanic applicant who had performed poorly on her anesthesiology rotation in medical school should be bumped up.” As it happened, he reports, “neither candidate was ultimately moved.”
(As for a case Sibarium mentions in which Lucero supposedly pushed to admit a Black student whose grades and test scores were below the UCLA average, he doesn’t say whether the student was admitted.)
It’s true that the UCLA entering medical school class has become more diverse over time. Figures issued by UCLA and published by the Beacon show that from 2019 through 2022, the number of whites in the 173-member class declined to 46 from 49, the number of Black students rose to 25 from 22, Hispanic students rose from 25 to 37, a catchall “other” category grew to 20 from eight, and American Indians, Hawaiians and other Pacific Islanders went from zero to three. The number of Asian students declined to 55 from 84.
Does this validate the article’s claim, voiced by an anonymous source, that “a third to a half of the medical school is incredibly unqualified”?
The math doesn’t pencil out. As blogger and statistics maven Kevin Drum notes, given that the number of nonwhite and non-Asian students increased by only 30 ion three years, even if “every single one of these students was woefully unqualified, that’s about 17% of the class. How do you get from there to ‘a third to a half’?”
By the way, the median grade point averages and scores on the Medical College Admission Test of accepted applicants haven’t declined at all since 2020 — the MCAT average in 2023 was the same as in 2020, and the GPA rose by a hair.
In emails to the medical school class, Dubinett and his fellow deans have reinforced their commitment to merit-based admissions and diversity training. “Students and faculty members are held to the highest standards of academic excellence,” they wrote. “Highly qualified medical students and trainees are admitted … based on merit in a process consistent with state and federal law.” That said, “we are enriched by the diverse experiences each of you brings to our community.”
UCLA, then, is standing firm against the right wing’s drive to pretend that racial and ethnic discrimination doesn’t exist in our society and to undermine efforts to wipe it out. Would that more institutions took that stand, instead of capitulating to a dishonest, braying mob.
Business
Commentary: A leading roboticist punctures the hype about self-driving cars, AI chatbots and humanoid robots
It may come to your attention that we are inundated with technological hype. Self-driving cars, human-like robots and AI chatbots all have been the subject of sometimes outlandishly exaggerated predictions and promises.
So we should be thankful for Rodney Brooks, an Australian-born technologist who has made it one of his missions in life to deflate the hyperbole about these and other supposedly world-changing technologies offered by promoters, marketers and true believers.
As I’ve written before, Brooks is nothing like a Luddite. Quite the contrary: He was a co-founder of IRobot, the maker of the Roomba robotic vacuum cleaner, though he stepped down as the company’s chief technology officer in 2008 and left its board in 2011. He’s a co-founder and chief technology officer of RobustAI, which makes robots for factories and warehouses, and former director of computer science and artificial intelligence labs at Massachusetts Institute of Technology.
Having ideas is easy. Turning them into reality is hard. Turning them into being deployed at scale is even harder.
— Rodney Brooks
In 2018, Brooks published a post of dated predictions about the course of major technologies and promised to revisit them annually for 32 years, when he would be 95. He focused on technologies that were then — and still are — the cynosures of public discussion, including self-driving cars, human space travel, AI bots and humanoid robots.
“Having ideas is easy,” he wrote in that introductory post. “Turning them into reality is hard. Turning them into being deployed at scale is even harder.”
Brooks slotted his predictions into three pigeonholes: NIML, for “not in my lifetime,” NET, for “no earlier than” some specified date, and “by some [specified] date.”
On Jan. 1 he published his eighth annual predictions scorecard. He found that over the years “my predictions held up pretty well, though overall I was a little too optimistic.”
For example in 2018 he predicted “a robot that can provide physical assistance to the elderly over multiple tasks [e.g., getting into and out of bed, washing, using the toilet, etc.]” wouldn’t appear earlier than 2028; as of New Year’s Day, he writes, “no general purpose solution is in sight.”
The first “permanent” human colony on Mars would come no earlier than 2036, he wrote then, which he now calls “way too optimistic.” He now envisions a human landing on Mars no earlier than 2040, and the settlement no earlier than 2050.
A robot that seems “as intelligent, as attentive, and as faithful, as a dog” — no earlier than 2048, he conjectured in 2018. “This is so much harder than most people imagine it to be,” he writes now. “Many think we are already there; I say we are not at all there.” His verdict on a robot that has “any real idea about its own existence, or the existence of humans in the way that a 6-year-old understands humans” — “Not in my lifetime.”
Brooks points out that one way high-tech promoters finesse their exaggerated promises is through subtle redefinition. That has been the case with “self-driving cars,” he writes. Originally the term referred to “any sort of car that could operate without a driver on board, and without a remote driver offering control inputs … where no person needed to drive, but simply communicated to the car where it should take them.”
Waymo, the largest purveyor of self-driven transport, says on its website that its robotaxis are “the embodiment of fully autonomous technology that is always in control from pickup to destination.” Passengers “can sit in the back seat, relax, and enjoy the ride with the Waymo Driver getting them to their destination safely.”
Brooks challenges this claim. One hole in the fabric of full autonomy, he observes, became clear Dec. 20, when a power blackout blanketing San Francisco stranded much of Waymo’s robotaxi fleet on the streets. Waymos, which can read traffic lights, clogged intersections because traffic lights went dark.
The company later acknowledged its vehicles occasionally “require a confirmation check” from humans when they encounter blacked-out traffic signals or other confounding situations. The Dec. 20 blackout, Waymo said, “created a concentrated spike in these requests,” resulting in “a backlog that, in some cases, led to response delays contributing to congestion on already-overwhelmed streets.”
It’s also known that Waymo pays humans to physically deal with vehicles immobilized by — for example — a passenger’s failure to fully close a car door when exiting. They can be summoned via the third-party app Honk, which chiefly is used by tow truck operators to find stranded customers.
“Current generation Waymos need a lot of human help to operate as they do, from people in the remote operations center to intervene and provide human advice for when something goes wrong, to Honk gig workers scampering around the city,” Brooks observes.
Waymo told me its claim of “fully autonomous” operation is based on the fact that the onboard technology is always in control of its vehicles. In confusing situations the car will call on Waymo’s “fleet response” team of humans, asking them to choose which of several optional paths is the best one. “Control of the vehicle is always with the Waymo Driver” — that is, the onboard technology, spokesman Mark Lewis told me. “A human cannot tele-operate a Waymo vehicle.”
As a pioneering robot designer, Brooks is particularly skeptical about the tech industry’s fascination with humanoid robots. He writes from experience: In 1998 he was building humanoid robots with his graduate students at MIT. Back then he asserted that people would be naturally comfortable with “robots with humanoid form that act like humans; the interface is hardwired in our brains,” and that “humans and robots can cooperate on tasks in close quarters in ways heretofore imaginable only in science fiction.”
Since then it has become clear that general-purpose robots that look and act like humans are chimerical. In fact in many contexts they’re dangerous. Among the unsolved problems in robot design is that no one has created a robot with “human-like dexterity,” he writes. Robotics companies promoting their designs haven’t shown that their proposed products have “multi-fingered dexterity where humans can and do grasp things that are unseen, and grasp and simultaneously manipulate multiple small objects with one hand.”
Two-legged robots have a tendency to fall over and “need human intervention to get back up,” like tortoises fallen on their backs. Because they’re heavy and unstable, they are “currently unsafe for humans to be close to when they are walking.”
(Brooks doesn’t mention this, but even in the 1960s the creators of “The Jetsons” understood that domestic robots wouldn’t rely on legs — their robot maid, Rosie, tooled around their household on wheels, a perception that came as second nature to animators 60 years ago but seems to have been forgotten by today’s engineers.)
As Brooks observes, “even children aged 3 or 4 can navigate around cluttered houses without damaging them. … By age 4 they can open doors with door handles and mechanisms they have never seen before, and safely close those doors behind them. They can do this when they enter a particular house for the first time. They can wander around and up and down and find their way.
“But wait, you say, ‘I’ve seen them dance and somersault, and even bounce off walls.’ Yes, you have seen humanoid robot theater. “
Brooks’ experience with artificial intelligence gives him important insights into the shortcomings of today’s crop of large language models — that’s the technology underlying contemporary chatbots — what they can and can’t do, and why.
“The underlying mechanism for Large Language Models does not answer questions directly,” he writes. “Instead, it gives something that sounds like an answer to the question. That is very different from saying something that is accurate. What they have learned is not facts about the world but instead a probability distribution of what word is most likely to come next given the question and the words so far produced in response. Thus the results of using them, uncaged, is lots and lots of confabulations that sound like real things, whether they are or not.”
The solution is not to “train” LLM bots with more and more data, in the hope that eventually they will have databases large enough to make their fabrications unnecessary. Brooks thinks this is the wrong approach. The better option is to purpose-build LLMs to fulfill specific needs in specific fields. Bots specialized for software coding, for instance, or hardware design.
“We need guardrails around LLMs to make them useful, and that is where there will be lot of action over the next 10 years,” he writes. “They cannot be simply released into the wild as they come straight from training. … More training doesn’t make things better necessarily. Boxing things in does.”
Brooks’ all-encompassing theme is that we tend to overestimate what new technologies can do and underestimate how long it takes for any new technology to scale up to usefulness. The hardest problems are almost always the last ones to be solved; people tend to think that new technologies will continue to develop at the speed that they did in their earliest stages.
That’s why the march to full self-driving cars has stalled. It’s one thing to equip cars with lane-change warnings or cruise control that can adjust to the presence of a slower car in front; the road to Level 5 autonomy as defined by the Society of Automotive Engineers — in which the vehicle can drive itself in all conditions without a human ever required to take the wheel — may be decades away at least. No Level 5 vehicles are in general use today.
Believing the claims of technology promoters that one or another nirvana is just around the corner is a mug’s game. “It always takes longer than you think,” Brooks wrote in his original prediction post. “It just does.”
Business
Versant launches, Comcast spins off E!, CNBC and MS NOW
Comcast has officially spun off its cable channels, including CNBC and MS NOW, into a separate company, Versant Media Group.
The transaction was completed late Friday. On Monday, Versant took a major tumble in its stock market debut — providing a key test of investors’ willingness to hold on to legacy cable channels.
The initial outlook wasn’t pretty, providing awkward moments for CNBC anchors reporting the story.
Versant fell 13% to $40.57 a share on its inaugural trading day. The stock opened Monday on Nasdaq at $45.17 per share.
Comcast opted to cast off the still-profitable cable channels, except for the perennially popular Bravo, as Wall Street has soured on the business, which has been contracting amid a consumer shift to streaming.
Versant’s market performance will be closely watched as Warner Bros. Discovery attempts to separate its cable channels, including CNN, TBS and Food Network, from Warner Bros. studios and HBO later this year. Warner Chief Executive David Zaslav’s plan, which is scheduled to take place in the summer, is being contested by the Ellison family’s Paramount, which has launched a hostile bid for all of Warner Bros. Discovery.
Warner Bros. Discovery has agreed to sell itself to Netflix in an $82.7-billion deal.
The market’s distaste for cable channels has been playing out in recent years. Paramount found itself on the auction block two years ago, in part because of the weight of its struggling cable channels, including Nickelodeon, Comedy Central and MTV.
Management of the New York-based Versant, including longtime NBCUniversal sports and television executive Mark Lazarus, has been bullish on the company’s balance sheet and its prospects for growth. Versant also includes USA Network, Golf Channel, Oxygen, E!, Syfy, Fandango, Rotten Tomatoes, GolfNow, GolfPass and SportsEngine.
“As a standalone company, we enter the market with the scale, strategy and leadership to grow and evolve our business model,” Lazarus, who is Versant’s chief executive, said Monday in a statement.
Through the spin-off, Comcast shareholders received one share of Versant Class A common stock or Versant Class B common stock for every 25 shares of Comcast Class A common stock or Comcast Class B common stock, respectively. The Versant shares were distributed after the close of Comcast trading Friday.
Comcast gained about 3% on Monday, trading around $28.50.
Comcast Chairman Brian Roberts holds 33% of Versant’s controlling shares.
Business
Ties between California and Venezuela go back more than a century with Chevron
As a stunned world processes the U.S. government’s sudden intervention in Venezuela — debating its legality, guessing who the ultimate winners and losers will be — a company founded in California with deep ties to the Golden State could be among the prime beneficiaries.
Venezuela has the largest proven oil reserves on the planet. Chevron, the international petroleum conglomerate with a massive refinery in El Segundo and headquartered, until recently, in San Ramon, is the only foreign oil company that has continued operating there through decades of revolution.
Other major oil companies, including ConocoPhillips and Exxon Mobil, pulled out of Venezuela in 2007 when then-President Hugo Chávez required them to surrender majority ownership of their operations to the country’s state-controlled oil company, PDVSA.
But Chevron remained, playing the “long game,” according to industry analysts, hoping to someday resume reaping big profits from the investments the company started making there almost a century ago.
Looks like that bet might finally pay off.
In his news conference Saturday, after U.S. Special Forces snatched Venezuelan President Nicolás Maduro and his wife in Caracas and extradited them to face drug-trafficking charges in New York, President Trump said the U.S. would “run” Venezuela and open more of its massive oil reserves to American corporations.
“We’re going to have our very large U.S. oil companies, the biggest anywhere in the world, go in, spend billions of dollars, fix the badly broken infrastructure, the oil infrastructure, and start making money for the country,” Trump said during a news conference Saturday.
While oil industry analysts temper expectations by warning it could take years to start extracting significant profits given Venezuela’s long-neglected, dilapidated infrastructure, and everyday Venezuelans worry about the proceeds flowing out of the country and into the pockets of U.S. investors, there’s one group who could be forgiven for jumping with unreserved joy: Chevron insiders who championed the decision to remain in Venezuela all these years.
But the company’s official response to the stunning turn of events has been poker-faced.
“Chevron remains focused on the safety and well-being of our employees, as well as the integrity of our assets,” spokesman Bill Turenne emailed The Times on Sunday, the same statement the company sent to news outlets all weekend. “We continue to operate in full compliance with all relevant laws and regulations.”
Turenne did not respond to questions about the possible financial rewards for the company stemming from this weekend’s U.S. military action.
Chevron, which is a direct descendant of a small oil company founded in Southern California in the 1870s, has grown into a $300-billion global corporation. It was headquartered in San Ramon, just outside of San Francisco, until executives announced in August 2024 that they were fleeing high-cost California for Houston.
Texas’ relatively low taxes and light regulation have been a beacon for many California companies, and most of Chevron’s competitors are based there.
Chevron began exploring in Venezuela in the early 1920s, according to the company’s website, and ramped up operations after discovering the massive Boscan oil field in the 1940s. Over the decades, it grew into Venezuela’s largest foreign investor.
The company held on over the decades as Venezuela’s government moved steadily to the left; it began to nationalize the oil industry by creating a state-owned petroleum company in 1976, and then demanded majority ownership of foreign oil assets in 2007, under then-President Hugo Chávez.
Venezuela has the world’s largest proven crude oil reserves — meaning they’re economical to tap — about 303 billion barrels, according to the U.S. Energy Information Administration.
But even with those massive reserves, Venezuela has been producing less than 1% of the world’s crude oil supply. Production has steadily declined from the 3.5 million barrels per day pumped in 1999 to just over 1 million barrels per day now.
Currently, Chevron’s operations in Venezuela employ about 3,000 people and produce between 250,000 and 300,000 barrels of oil per day, according to published reports.
That’s less than 10% of the roughly 3 million barrels the company produces from holdings scattered across the globe, from the Gulf of Mexico to Kazakhstan and Australia.
But some analysts are optimistic that Venezuela could double or triple its current output relatively quickly — which could lead to a windfall for Chevron.
The Associated Press contributed to this report.
-
World1 week agoHamas builds new terror regime in Gaza, recruiting teens amid problematic election
-
News1 week agoFor those who help the poor, 2025 goes down as a year of chaos
-
Business1 week agoInstacart ends AI pricing test that charged shoppers different prices for the same items
-
World1 week agoPodcast: The 2025 EU-US relationship explained simply
-
Business1 week agoApple, Google and others tell some foreign employees to avoid traveling out of the country
-
Technology1 week agoChatGPT’s GPT-5.2 is here, and it feels rushed
-
Politics1 week ago‘Unlucky’ Honduran woman arrested after allegedly running red light and crashing into ICE vehicle
-
Health1 week agoDid holiday stress wreak havoc on your gut? Doctors say 6 simple tips can help